vendredi 29 avril 2016

Onco Actu du 29 avril 2016

2.6 Etiologie - Environnement

Radon and Hematologic Cancer in Women [ACS]

Exposure to Particulate Air Pollutants Associated With Numerous Types of Cancer [AACR]

4.10 Dép., diag. & prono. - FDA, EMA, NICE,...

There’s a new sheriff in town in Silicon Valley — the FDA [Washington Post]

5. Traitements

Rise of the Cancer Avatars: Implanting Mice With Our Malignancies [Undark]

5.12 Immunothérapies

Immune Checkpoint Therapeutics - Hot Targets & Pipeline Analysis [ReportLinker]

5.12.2 Immunothérapies - CAR-T

Kite Pharma Announces Presentations at the Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT) [KITE]

5.2.2 Pharma - Fusions & Acquisitions

Stemcentrx Scooped Up [In the Pipeline]

In M&A Bonanza, AbbVie, Sanofi Throw Billions at Stemcentrx, Medivation [Xconomy]

A frustrated Sanofi makes $9.3 billion bid for Medivation and its cancer drug [STAT]

Health Care Companies See Scale as the Only Way to Compete [NY Times]

Sanofi launches $9.3 billion fight for U.S. cancer firm Medivation [Reuters]

Biotech Dumb Money Looks Smart in $6 Billion Stemcentrx Sale [MIT Technology Review]

AbbVie forges deeper into cancer, as clock ticks for Humira [Reuters]

5.3 Traitements - FDA, EMA,...

FDA sued for hiding too much info about its expert panel members [STAT]

5.4 Traitements - Economie

Costs for Orally Administered Cancer Drugs Skyrocket [UNC Lineberger Comprehensive Cancer Center]

NICE recommends combined drug therapy proven to extend life for skin cancer [NICE]

Express Scripts plans fiercer fight against sudden drug price hikes [Reuters]

6.5 Médecines alternatives

Cassandra Callender, the teen who refused chemotherapy, has relapsed [Respectful Insolence]